3M-Brazzein as a Natural Sugar Substitute Attenuates Obesity, Metabolic Disorder, and Inflammation

J Agric Food Chem. 2020 Feb 19;68(7):2183-2192. doi: 10.1021/acs.jafc.0c00317. Epub 2020 Feb 7.

Abstract

Obesity is a global chronic disease linked to various diseases. Increased consumption of added sugars, especially in beverages, is a key contributor to the obesity epidemic. It is essential to reduce or replace sugar intake with low-calorie sweeteners. Here, a natural sweet protein, 3M-brazzein, was investigated as a possible sugar substitute. Mice were exposed to 3M-brazzein or 10% sucrose of equivalent sweetness, in drinking water to mimic human obesity development over 15 weeks. Consumption of 3M-brazzein in liquid form did not cause adiposity hypertrophy, resulting in 33.1 ± 0.4 g body weight and 0.90 ± 0.2 mm fat accumulation, which were 35.9 ± 0.7 g (p = 0.0094) and 1.53 ± 0.067 mm (p = 0.0031), respectively, for sucrose supplement. Additionally, 3M-brazzein did not disrupt glucose homeostasis or affect insulin resistance and inflammation. Due to its naturally low-calorie content, 3M-brazzein could also be a potential sugar substitute that reduces adiposity.

Keywords: brazzein; low-calorie sweetener; metabolic disorder; obesity; sugar substitute.

MeSH terms

  • Adiposity
  • Animals
  • Body Weight
  • Energy Intake
  • Humans
  • Insulin Resistance
  • Kluyveromyces / genetics
  • Kluyveromyces / metabolism
  • Male
  • Metabolic Diseases / immunology
  • Metabolic Diseases / metabolism*
  • Metabolic Diseases / physiopathology
  • Mice
  • Mice, Inbred C57BL
  • Obesity / immunology
  • Obesity / metabolism*
  • Obesity / physiopathology
  • Plant Proteins / genetics
  • Plant Proteins / metabolism*
  • Sweetening Agents / metabolism*

Substances

  • Plant Proteins
  • Sweetening Agents
  • brazzein protein, Pentadiplandra brazzeana